Not applicableActive Not RecruitingNCT05043857What this trial is testingStereotactic PAncreatic RadioTherapy Adjuvant TherapyWho this might be right forPancreas Cancer Istituto Clinico Humanitas 50
Testing effectiveness (Phase 2)UnknownNCT04029428What this trial is testingPeptide Receptor Radionuclide Therapy in the Treatment of Advanced, Non-resectable and/or Symptomatic Tumors With SSTR OverexpressionWho this might be right forNeuroendocrine Tumors University of Warmia and Mazury 150
Not applicableLooking for participantsNCT06937112What this trial is testing18F Labeled FAP Targeted Molecular Probe in Early Tumor DiagnosisWho this might be right forLung CancersPancreatic CancerNeuroendocrine Tumors+1 more Nanjing First Hospital, Nanjing Medical University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06766019What this trial is testingAdebrelimab Combined With Irinotecan Liposomal (II), Oxaliplatin, and 5-FU/LV Conversion Therapy for Locally Advanced Pancreatic CancerWho this might be right forPancreatic Cancer The First Affiliated Hospital with Nanjing Medical University 47
Not applicableLooking for participantsNCT07274657What this trial is testingSuperb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2D-SWE-EUS) in Differential Diagnosis of Pancreatic Adenocarcinoma (PA) From Other Pancreatic Solid Lesions (PSLs) and Pancreatic neuroendocrinE Tumors (pNETs) MalignancyWho this might be right forPancreas Adenocarcinoma (MSI-H)Pancreatic Neuroendocrine Tumors (pNET) GCS Ramsay Santé pour l'Enseignement et la Recherche 150
Early research (Phase 1)Study completedNCT01497392What this trial is testingDovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary CancersWho this might be right forAdenocarcinoma of the PancreasStage III Pancreatic CancerStage IV Pancreatic Cancer+1 more Roswell Park Cancer Institute 26
Not applicableStudy completedNCT01931644What this trial is testingAt-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsWho this might be right forAll Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more Sanguine Biosciences 17,667
Not applicableNot Yet RecruitingNCT07418164What this trial is testingEndoscopic Management of Biliopancreatic Disease in the Lombardy Pancreas UnitsWho this might be right forPancreatic CancerBiliopancreatic DiseasesPeriampullary Neoplasms IRCCS San Raffaele 2,500
Testing effectiveness (Phase 2)Study completedNCT00837239What this trial is testingHuachansu & Gemcitabine in Pancreatic CancerWho this might be right forPancreatic Cancer M.D. Anderson Cancer Center 80
Large-scale testing (Phase 3)UnknownNCT02506842What this trial is testingSecond-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative ResectionWho this might be right forStage ⅠA Pancreatic CancerStage ⅠB Pancreatic CancerStage ⅡA Pancreatic Cancer+1 more Fudan University 300
Very early researchEnded earlyNCT00414570What this trial is testingAn Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside AnalogsWho this might be right forPancreatic Cancer AHS Cancer Control Alberta 11
Not applicableLooking for participantsNCT07407231What this trial is testingCombined Chemotherapy And Ablative Radiotherapy (SBRT) As First-Line Treatment In Locally Advanced Inoperable Pancreatic Cancer (SBRT-PANC)Who this might be right forLocally Advanced Pancreatic Cancer Institute of Oncology Ljubljana 18
Not applicableStudy completedNCT07034495What this trial is testingLaparotomy, Laparoscopy, da Vinci SystemWho this might be right forStomach NeoplasmsPancreatic NeoplasmsLiver Neoplasms+5 more National Chung Hsing University 486
Early research (Phase 1)Not Yet RecruitingNCT07700212What this trial is testingTrial Of Safety And Initial Efficacy Of Vagal Nerve Blockade For Cancer-Induced Cachexia In Patients With Metastatic Pancreatic AdenocarcinomaWho this might be right forMetastatic Pancreatic Adenocarcinoma M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT01040000What this trial is testingQUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal CancerWho this might be right forMetastatic Pancreatic CancerMetastatic Colorectal Cancer Precision Biologics, Inc 94
Testing effectiveness (Phase 2)Temporarily pausedNCT03919292What this trial is testingNeratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated CaWho this might be right forSolid Tumor, Adult Virginia Commonwealth University 83
Not applicableUnknownNCT06155136What this trial is testingRWE on Patients With mPDAC Long-term Survival After Treatment With Liposomal IrinotecanWho this might be right forPancreatic Cancer Metastatic Servier Affaires Médicales 163
Early research (Phase 1)Active Not RecruitingNCT06532344What this trial is testingAn Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic CancerWho this might be right forMetastatic Pancreatic Cancer Ono Pharmaceutical Co., Ltd. 32
Testing effectiveness (Phase 2)Study completedNCT02807844What this trial is testingPhase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced MalignanciesWho this might be right forTriple Negative Breast CancerPancreatic CarcinomaMelanoma+1 more Novartis Pharmaceuticals 141
Testing effectiveness (Phase 2)Active Not RecruitingNCT04083599What this trial is testingGEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid TumorsWho this might be right forMalignant Solid TumorNon-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+3 more Genmab 350